Screening, identification and quantitation of benzodiazepines in serum by solid phase extraction on a cyanopropyl phase using high performance liquidchromatography and photodiode array detection

Citation
B. Ahrens et al., Screening, identification and quantitation of benzodiazepines in serum by solid phase extraction on a cyanopropyl phase using high performance liquidchromatography and photodiode array detection, ARZNEI-FOR, 50(12), 2000, pp. 1057-1062
Citations number
14
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
ISSN journal
00044172 → ACNP
Volume
50
Issue
12
Year of publication
2000
Pages
1057 - 1062
Database
ISI
SICI code
0004-4172(200012)50:12<1057:SIAQOB>2.0.ZU;2-S
Abstract
A screening procedure for benzodiazepines in serum is presented. The compou nds are extracted over a cyanopropyl phase followed by identification and d etermination via high performance liquid chromatography and photodiode arra y detection. Diazepam (CAS 439-14-5), flunitrazepam (CAS 1622-62-4), nordaz epam (CAS 1088-11-5), oxazepam (CAS 604-75-1) and temazepam (CAS 846-50-4) are quantified. Retention data of 42 benzodiazepines and their metabolites as well as hydrolysis products are listed. This assay leads to an expansion of a known systematic toxicological analysis system to identify pharmaceut icals, drugs of abuse and pesticides.